X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-04 | NTLA | Basta James | EVP, GC | S - Sale+OE | $32.99 | -2,297 | 81,571 | -3% | -$75,778 | |||||
| D | 2024-03-04 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale+OE | $32.99 | -605 | 71,470 | -1% | -$19,959 | |||||
2024-01-08 | NTLA | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S - Sale | $28.87 | -2,275 | 43,927 | -5% | -$65,682 | ||||||
2024-01-03 | NTLA | Leonard John M | Pres, CEO | S - Sale | $29.46 | -19,223 | 904,901 | -2% | -$566,310 | ||||||
2024-01-03 | NTLA | Lebwohl David | EVP, Chief Medical Officer | S - Sale | $29.46 | -5,843 | 54,372 | -10% | -$172,135 | ||||||
2024-01-03 | NTLA | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S - Sale | $29.46 | -5,532 | 46,202 | -11% | -$162,973 | ||||||
2024-01-03 | NTLA | Goddard Glenn | EVP, CFO | S - Sale | $29.46 | -5,365 | 40,585 | -12% | -$158,053 | ||||||
2024-01-03 | NTLA | Hicks Derek | EVP, Chief Business Officer | S - Sale | $29.46 | -3,877 | 36,987 | -9% | -$114,216 | ||||||
2024-01-03 | NTLA | Basta James | EVP, GC | S - Sale | $29.46 | -3,805 | 51,474 | -7% | -$112,095 | ||||||
2024-01-03 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale | $29.50 | -4,608 | 40,845 | -10% | -$135,954 | ||||||
2023-10-31 | NTLA | Bhanji Muna | Dir | S - Sale | $23.90 | -265 | 11,996 | -2% | -$6,334 | ||||||
2023-07-31 | NTLA | Bhanji Muna | Dir | S - Sale | $42.33 | -265 | 12,261 | -2% | -$11,217 | ||||||
2023-07-06 | NTLA | Bhanji Muna | Dir | S - Sale | $39.30 | -1,867 | 12,526 | -13% | -$73,373 | ||||||
2023-07-03 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale | $40.51 | -360 | 45,146 | -1% | -$14,584 | ||||||
| D | 2023-06-20 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale+OE | $45.00 | -5,000 | 45,146 | -10% | -$225,000 | |||||
| D | 2023-03-02 | NTLA | Basta James | EVP, GC | S - Sale+OE | $43.88 | -1,088 | 55,279 | -2% | -$47,741 | |||||
| M | 2023-01-04 | NTLA | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S - Sale | $37.82 | -4,838 | 17,629 | -22% | -$182,982 | |||||
2023-01-04 | NTLA | Leonard John M | Pres, CEO | S - Sale | $37.21 | -6,673 | 825,240 | -1% | -$248,302 | ||||||
2023-01-04 | NTLA | Hicks Derek | EVP, Chief Business Officer | S - Sale | $37.21 | -1,812 | 17,306 | -9% | -$67,425 | ||||||
2023-01-04 | NTLA | Lebwohl David | EVP, Chief Medical Officer | S - Sale | $37.21 | -2,574 | 25,687 | -9% | -$95,779 | ||||||
2023-01-04 | NTLA | Goddard Glenn | EVP, CFO | S - Sale | $37.21 | -2,427 | 15,404 | -14% | -$90,309 | ||||||
| M | 2022-07-01 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale | $37.65 | -2,028 | 14,473 | -12% | -$76,357 | |||||
2023-01-04 | NTLA | Basta James | EVP, GC | S - Sale | $37.21 | -1,138 | 19,559 | -5% | -$42,345 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |